J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krimbou, L.
Right arrow Articles by Cohn, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krimbou, L.
Right arrow Articles by Cohn, J. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 38, 35-48, Copyright © 1997 by Lipid Research, Inc.


ARTICLES

Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre- beta1-LpE, pre-beta2-LpE, and alpha-LpE

L Krimbou, M Tremblay, J Davignon and JS Cohn
Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Quebec, Canada.

We have used two-dimensional gel electrophoresis to separate and characterize human plasma apolipoprotein (apo) E-containing lipoproteins in the high density lipoprotein (HDL) size range. Lipoproteins were separated from whole plasma by electrophoresis (according to charge) in a 0.75% agarose gel, and then in the second dimension (according to size) in a 2-15% non-denaturing polyacrylamide gradient gel. ApoE-containing lipoproteins were detected by radiography after electrotransfer of lipoproteins to nitrocellulose membranes and incubation with 125I-labeled affinity-purified polyclonal apoE antibody. ApoE-containing lipoproteins in the HDL size range had a particle size ranging from 9 to 18.5 nm in diameter and could be characterized as having either gamma, pre-beta1-, pre-beta2- or alpha- electrophoretic mobility (designated gamma-LpE, pre-beta1-LpE, pre- beta2LpE, and alpha-LpE respectively). gamma-LpE and a substantial proportion of pre-beta1- and pre-beta2-LpE did not co-migrate with apoA- I, apoA-II, apoC-III, or apoB-100. Subsequent experiments focused on the pre-beta1-LpE, pre-beta2LpE, and alpha-LpE subfractions, which represented > 95% of apoE in HDL-sized lipoproteins. Storage of plasma at 4 degrees C or in vitro incubation of plasma at 37 degrees C caused a relative decrease in pre-beta1-LpE and increase in alpha-LpE. Normolipidemic patients with an apoE 2/2 phenotype tended to have increased levels of alpha-LpE, whereas apoE 4/4 subjects tended to have a greater proportion of HDL-apoE as pre-beta1-LpE. Decrease in plasma HDL apoE concentration after an oral fat load was associated with a reduction in the plasma concentration of all HDL-apoE subfractions. These results demonstrate that: 1) apoE-containing HDL are heterogeneous in size and charge; 2) pre-beta1-LpE is a relatively labile HDL subfraction; 3) HDL-apoE subfraction distribution is dependent on apoE phenotype; and 4) all apoE-containing HDL subfractions participate in the plasma transfer of apoE during the postprandial period.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
N. Settasatian, P. J. Barter, and K.-A. Rye
Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein
J. Lipid Res., January 1, 2008; 49(1): 115 - 126.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Guerin, W. Le Goff, E. Duchene, Z. Julia, T. Nguyen, T. Thuren, C. L. Shear, and M. J. Chapman
Inhibition of CETP by Torcetrapib Attenuates the Atherogenicity of Postprandial TG-Rich Lipoproteins in Type IIB Hyperlipidemia
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 148 - 154.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. Skropeta, C. Settasatian, M. R. McMahon, K. Shearston, D. Caiazza, K. C. McGrath, W. Jin, D. J. Rader, P. J. Barter, and K.-A. Rye
N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins
J. Lipid Res., September 1, 2007; 48(9): 2047 - 2057.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K.-A. Rye, R. Bright, M. Psaltis, and P. J. Barter
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E
J. Lipid Res., May 1, 2006; 47(5): 1025 - 1036.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
I. L. Ruel, P. Couture, J. S. Cohn, A. Bensadoun, M. Marcil, and B. Lamarche
Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism
J. Lipid Res., August 1, 2004; 45(8): 1528 - 1537.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Krimbou, M. Denis, B. Haidar, M. Carrier, M. Marcil, and J. Genest Jr.
Molecular interactions between apoE and ABCA1: impact on apoE lipidation
J. Lipid Res., May 1, 2004; 45(5): 839 - 848.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. S. Cohn, R. Batal, M. Tremblay, H. Jacques, L. Veilleux, C. Rodriguez, O. Mamer, and J. Davignon
Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism
J. Lipid Res., October 1, 2003; 44(10): 1976 - 1983.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Krimbou, M. Marcil, H. Chiba, and J. Genest Jr.
Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles
J. Lipid Res., May 1, 2003; 44(5): 884 - 892.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Shi, X. Wang, K. Tangchitpiyanond, J. Wong, Y. Shi, and A. J. Lusis
Atherosclerosis in C3H/HeJ Mice Reconstituted With Apolipoprotein E-Null Bone Marrow
Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 650 - 655.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. D. Harris, I. R. Graham, S. Schepelmann, A. K. Stannard, M. L. Roberts, B. L. Hodges, V. Hill, A. Amalfitano, D. G. Hassall, J. S. Owen, et al.
Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1-, E3-, polymerase-] adenovirus vector expressing human apoE
Hum. Mol. Genet., January 1, 2002; 11(1): 43 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Barlage, D. Fröhlich, A. Böttcher, M. Jauhiainen, H. P. Müller, F. Noetzel, G. Rothe, C. Schütt, R. P. Linke, K. J. Lackner, et al.
ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response
J. Lipid Res., February 1, 2001; 42(2): 281 - 290.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
T. Athanasopoulos, J. S. Owen, D. Hassall, M. G. Dunckley, J. Drew, J. Goodman, A. D. Tagalakis, D. R. Riddell, and G. Dickson
Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice
Hum. Mol. Genet., October 1, 2000; 9(17): 2545 - 2551.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Böttcher, J. Schlosser, F. Kronenberg, H. Dieplinger, G. Knipping, K. J. Lackner, and G. Schmitz
Preparative free-solution isotachophoresis for separation of human plasma lipoproteins: apolipoprotein and lipid composition of HDL subfractions
J. Lipid Res., June 1, 2000; 41(6): 905 - 915.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
A. Schlenck, B. Herbeth, G. Siest, and S. Visvikis
Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
J. Lipid Res., November 1, 1999; 40(11): 2125 - 2133.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Tsukamoto, R. Tangirala, S. H. Chun, E. Pure, and D. J. Rader
Rapid Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of ApoE in ApoE-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2162 - 2170.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Marcoux, M. Tremblay, K. Nakajima, J. Davignon, and J. S. Cohn
Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients
J. Lipid Res., April 1, 1999; 40(4): 636 - 647.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Marcil, L. Yu, L. Krimbou, B. Boucher, J. F. Oram, J. S. Cohn, and J. Genest Jr
Cellular Cholesterol Transport and Efflux in Fibroblasts Are Abnormal in Subjects With Familial HDL Deficiency
Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 159 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Krimbou, M. Tremblay, J. Davignon, and J. S. Cohn
Association of apolipoprotein E with {alpha}2-macroglobulin in human plasma
J. Lipid Res., December 1, 1998; 39(12): 2373 - 2386.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Zhu, S. Bellosta, C. Langer, F. Bernini, R. E. Pitas, R. W. Mahley, G. Assmann, and A. von Eckardstein
Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma
PNAS, June 23, 1998; 95(13): 7585 - 7590.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. Lamarche, K. D. Uffelman, G. Steiner, P. H. R. Barrett, and G. F. Lewis
Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model
J. Lipid Res., June 1, 1998; 39(6): 1162 - 1172.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
L. Krimbou, M. Tremblay, H. Jacques, J. Davignon, and J. S. Cohn
In vitro factors affecting the concentration of gamma-LpE ({gamma}-LpE) in human plasma
J. Lipid Res., April 1, 1998; 39(4): 861 - 872.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Batal, M. Tremblay, L. Krimbou, O. Mamer, J. Davignon, J. Genest Jr, and J. S. Cohn
Familial HDL Deficiency Characterized by Hypercatabolism of Mature ApoA-I but Not ProApoA-I
Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 655 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. K. Tangirala, D. Pratico, G. A. FitzGerald, S. Chun, K. Tsukamoto, C. Maugeais, D. C. Usher, E. Pure, and D. J. Rader
Reduction of Isoprostanes and Regression of Advanced Atherosclerosis by Apolipoprotein E
J. Biol. Chem., January 5, 2001; 276(1): 261 - 266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Krimbou, M. Marcil, J. Davignon, and J. Genest Jr.
Interaction of Lecithin:Cholesterol Acyltransferase (LCAT){middle dot}alpha 2-Macroglobulin Complex with Low Density Lipoprotein Receptor-related Protein (LRP). EVIDENCE FOR AN alpha 2-MACROGLOBULIN/LRP RECEPTOR-MEDIATED SYSTEM PARTICIPATING IN LCAT CLEARANCE
J. Biol. Chem., August 24, 2001; 276(35): 33241 - 33248.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Shi, X. Wang, K. Tangchitpiyanond, J. Wong, Y. Shi, and A. J. Lusis
Atherosclerosis in C3H/HeJ Mice Reconstituted With Apolipoprotein E-Null Bone Marrow
Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 650 - 655.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.